Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker

BACKGROUND: To evaluate if white matter lesions (WML) on MRI can be a potential marker for onabotulinum toxin A (Botox®) treatment success in migraine, given the limited response rate and high costs per treatment. METHODS: Retrospective data base and MRI analysis of 529 migraineurs who received Boto...

Descripción completa

Detalles Bibliográficos
Autores principales: Bumb, Anja, Seifert, Burkhard, Wetzel, Stephan, Agosti, Reto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755787/
https://www.ncbi.nlm.nih.gov/pubmed/24010035
http://dx.doi.org/10.1186/2193-1801-2-377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755787/
https://www.ncbi.nlm.nih.gov/pubmed/24010035
http://dx.doi.org/10.1186/2193-1801-2-377

Ejemplares similares